Llama-derived nanobodies show neutralizing activity against SARS-CoV-2 variants of concern in vitro

By | February 19, 2021
A new study reports the development of nanoantibodies (nAbs) – also called or nanobodiesTM or single-domain antibodies – that effectively bind the SARS-CoV-2 spike protein from the ancestral Wuhan variant as well as the recently detected UK and South African variants.